Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Diluted Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)

VISTAGEN THERAPEUTICS, INC. (VTGN) reported Diluted Shares Outstanding (Weighted Average) of 42.98 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14

  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 42.98M shares, a 34.60% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 42.33M shares, a 34.13% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 42.23M shares, a 37.52% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 35.75M shares, a 16.70% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2026 was 38.07M shares, a 23.31% increase from fiscal 2025.
  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 30.88M shares, a 59.53% increase from fiscal 2024.
  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 19.35M shares, a 178.13% increase from fiscal 2023.
  • VISTAGEN THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 6.96M shares.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Diluted 12 monthWeighted Average Number of Shares Outstanding, Diluted 12 month as first filed
2026-06-3042.98M shares
10-Q · filed 2026-08-14
42.66M shares
derived: average of 2 quarters · filed 2026-08-14
42.51M shares
derived: average of 3 quarters · filed 2026-08-14
40.82M shares
derived: average of 4 quarters · filed 2026-08-14
2026-03-3142.33M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
42.28M shares
derived: average of 2 quarters · filed 2026-06-15
40.10M shares
derived: average of 3 quarters · filed 2026-06-15
38.07M shares
10-K · filed 2026-06-15
2025-12-3142.23M shares
10-Q · filed 2026-02-12
38.99M shares
derived: average of 2 quarters · filed 2026-02-12
36.66M shares
10-Q · filed 2026-02-12
35.37M shares
derived: average of 4 quarters · filed 2026-08-14
2025-09-3035.75M shares
10-Q · filed 2025-11-13
33.85M shares
10-Q · filed 2025-11-13
33.08M shares
derived: average of 3 quarters · filed 2026-08-14
32.49M shares
derived: average of 4 quarters · filed 2026-08-14
2025-06-3031.93M shares
10-Q · filed 2026-08-14
31.75M shares
derived: average of 2 quarters · filed 2026-08-14
31.40M shares
derived: average of 3 quarters · filed 2026-08-14
31.21M shares
derived: average of 4 quarters · filed 2026-08-14
2025-03-3131.56M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15
31.14M shares
derived: average of 2 quarters · filed 2026-06-15
30.97M shares
derived: average of 3 quarters · filed 2026-06-15
30.88M shares
10-K · filed 2026-06-15
2024-12-3130.71M shares
10-Q · filed 2026-02-12
30.67M shares
derived: average of 2 quarters · filed 2026-02-12
30.65M shares
10-Q · filed 2026-02-12
30.62M shares
derived: average of 4 quarters · filed 2026-02-12
2024-09-3030.63M shares
10-Q · filed 2025-11-13
30.62M shares
10-Q · filed 2025-11-13
30.59M shares
derived: average of 3 quarters · filed 2025-11-13
30.29M shares
derived: average of 4 quarters · filed 2025-11-13
2024-06-3030.60M shares
10-Q · filed 2025-08-07
30.56M shares
derived: average of 2 quarters · filed 2025-08-07
30.17M shares
derived: average of 3 quarters · filed 2025-08-07
25.14M shares
derived: average of 4 quarters · filed 2025-08-07
2024-03-3130.52M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17
29.95M shares
derived: average of 2 quarters · filed 2025-06-17
23.32M shares
derived: average of 3 quarters · filed 2025-06-17
19.35M shares
10-K · filed 2025-06-17
2023-12-3129.39M shares
10-Q · filed 2025-02-13
19.72M shares
derived: average of 2 quarters · filed 2025-02-13
15.63M shares
10-Q · filed 2025-02-13
2023-09-3010.04M shares
10-Q · filed 2024-11-07
8.72M shares
10-Q · filed 2024-11-07
2023-06-307.34M shares
10-Q · filed 2024-08-13
2023-03-316.96M shares
10-K · filed 2024-06-11
2016-03-312.12M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-24
1.94M shares
derived: average of 2 quarters · filed 2016-06-24
1.84M shares
derived: average of 3 quarters · filed 2016-06-24
1.77M shares
10-K · filed 2016-06-24
2015-12-311.77M shares
10-Q · filed 2016-02-16
1.70M shares
derived: average of 2 quarters · filed 2016-02-16
1.65M shares
10-Q · filed 2016-02-16
2015-09-301.62M shares
10-Q · filed 2015-11-16
1.59M shares
10-Q · filed 2015-11-16
2015-03-311.47M shares
10-K · filed 2016-06-24
1.47M shares
10-K · filed 2015-06-29
1.38M shares
derived: average of 2 quarters · filed 2016-06-24
1.36M shares
derived: average of 3 quarters · filed 2016-06-24
1.32M shares
10-K · filed 2016-06-24
1.32M shares
10-K · filed 2015-06-29
2014-12-311.30M shares
10-K · filed 2016-06-24
1.30M shares
10-Q · filed 2015-02-17
1.30M shares
derived: average of 2 quarters · filed 2016-06-24
1.29M shares
10-Q · filed 2016-02-16
1.25M shares
derived: average of 4 quarters · filed 2016-06-24
2014-09-301.30M shares
10-K · filed 2016-06-24
1.30M shares
10-Q · filed 2014-11-19
1.25M shares
10-Q · filed 2015-11-16
1.23M shares
derived: average of 3 quarters · filed 2016-06-24
1.20M shares
derived: average of 4 quarters · filed 2016-06-24
2014-06-301.23M shares
10-K · filed 2016-06-24
24.59M shares
10-Q · filed 2014-08-12
1.20M shares
derived: average of 2 quarters · filed 2016-06-24
1.17M shares
derived: average of 3 quarters · filed 2016-06-24
1.16M shares
derived: average of 4 quarters · filed 2016-06-24
2014-03-311.16M shares
10-K · filed 2015-06-29
1.14M shares
derived: average of 2 quarters · filed 2015-06-29
1.13M shares
derived: average of 3 quarters · filed 2015-06-29
1.10M shares
10-K · filed 2015-06-29
21.97M shares
10-K · filed 2014-06-25
2013-12-311.11M shares
10-K · filed 2015-06-29
22.21M shares
10-Q · filed 2014-02-14
1.12M shares
derived: average of 2 quarters · filed 2015-06-29
1.09M shares
10-Q · filed 2015-02-17
21.55M shares
10-Q · filed 2014-02-14
5.88M shares
derived: average of 4 quarters · filed 2015-06-29
2013-09-301.13M shares
10-K · filed 2015-06-29
1.11M shares
10-Q · filed 2014-11-19
7.48M shares
derived: average of 3 quarters · filed 2015-06-29
10.18M shares
derived: average of 4 quarters · filed 2015-06-29
2013-06-301.06M shares
10-K · filed 2015-06-29
21.23M shares
10-Q · filed 2013-08-14
10.65M shares
derived: average of 2 quarters · filed 2015-06-29
13.20M shares
derived: average of 3 quarters · filed 2015-06-29
14.17M shares
derived: average of 4 quarters · filed 2015-06-29
2013-03-3120.24M shares
10-K · filed 2013-07-18
19.26M shares
derived: average of 2 quarters · filed 2014-02-14
18.54M shares
derived: average of 3 quarters · filed 2014-02-14
20.84M shares
10-Q · filed 2014-08-12
18.11M shares
10-K · filed 2013-07-18
2012-12-3118.29M shares
10-Q · filed 2014-02-14
17.69M shares
derived: average of 2 quarters · filed 2014-02-14
17.41M shares
10-Q · filed 2014-02-14
17.19M shares
derived: average of 4 quarters · filed 2014-02-14
2012-09-3017.09M shares
10-K · filed 2013-07-18
16.84M shares
10-Q · filed 2012-11-14
16.97M shares
10-Q · filed 2012-11-14
16.83M shares
derived: average of 3 quarters · filed 2013-08-14
16.63M shares
derived: average of 4 quarters · filed 2013-08-14
2012-06-3016.84M shares
10-Q · filed 2013-08-14
16.69M shares
derived: average of 2 quarters · filed 2013-08-14
16.47M shares
derived: average of 3 quarters · filed 2013-08-14
16.17M shares
derived: average of 4 quarters · filed 2013-08-14
2012-03-3116.54M shares
10-K · filed 2013-07-18
16.29M shares
derived: average of 2 quarters · filed 2013-07-18
15.94M shares
derived: average of 3 quarters · filed 2013-07-18
14.74M shares
10-K · filed 2013-07-18
2011-12-3116.04M shares
10-K · filed 2013-07-18
15.64M shares
derived: average of 2 quarters · filed 2013-07-18
14.14M shares
10-Q · filed 2013-02-14
11.91M shares
derived: average of 4 quarters · filed 2013-07-18
2011-09-3015.24M shares
10-K · filed 2013-07-18
13.24M shares
10-Q · filed 2012-11-14
10.53M shares
derived: average of 3 quarters · filed 2013-07-18
9.21M shares
derived: average of 4 quarters · filed 2013-07-18
2011-06-3011.11M shares
10-K · filed 2013-07-18
10.77M shares
10-Q · filed 2011-08-22
8.17M shares
derived: average of 2 quarters · filed 2013-07-18
7.20M shares
derived: average of 3 quarters · filed 2013-07-18
6.71M shares
derived: average of 4 quarters · filed 2013-07-18
2011-03-315.24M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02
5.24M shares
derived: average of 2 quarters · filed 2012-07-02
5.24M shares
derived: average of 3 quarters · filed 2012-07-02
5.24M shares
10-K · filed 2012-07-02
2010-12-315.24M shares
10-Q · filed 2012-02-14
5.24M shares
derived: average of 2 quarters · filed 2012-02-14
5.24M shares
10-Q · filed 2012-02-14
2010-09-305.24M shares
10-Q · filed 2011-11-14
5.24M shares
10-Q · filed 2011-11-14
2010-06-305.24M shares
10-Q · filed 2011-08-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B